🔎 Trials Near Me

Akèy › Kansè lestomak › Michigan › Grand Rapids

Etid klinik pou Kansè lestomak nan Grand Rapids, MI

18 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote Grand Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Ap rekriteVolontè an sante akeyi
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Ap rekriteFaz 2
  • Research Site, Grand Rapids
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Ap rekriteFaz 1
  • BAMF Health Inc., Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Ap rekriteFaz 1
  • BAMF Health Inc., Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • START Midwest, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Ap rekriteFaz 1/2
  • START Midwest, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05267626

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Ap rekriteFaz 1
  • START - Midwest Cancer Research Center, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07115043

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • START Midwest, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Ap rekriteFaz 1
  • START Midwest, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06131840

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Ap rekriteFaz 2
  • Research Site, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05702229

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Ap rekriteFaz 1/2
  • START Midwest, Grand Rapids
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Ap rekriteFaz 1/2
  • BAMF Health, Inc., Grand Rapids
Laj 15 ak plis · Tout sèks · Mizajou Aug 12, 2025 · NCT06298916

Etid Kansè lestomak nan lòt vil

Lòt etid nan Grand Rapids

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.